Updated: June 13, 2026
Highbury Group logo
VC Fund
Venture Capital Firm
Consumer
Enterprise

Highbury Group

USA

About the program

Investment focus areas
Description

Solo-GP Dr. Ling Wong (MIT, Harvard PhD; inventor of the first inhaled TB vaccine) invests $500Kโ€“$50M seed through growth, bringing scientific expertise, breakout-company track record and top-tier co-investor access.

Location

Investment offer

Check size$500 โ€“ $50,000,000
Can lead rounds
No
Details

Avg Check: $100K - $10M ยท

Funding requirements

We invest in technology companies that aim to transform the future.